Added to YB: 2025-07-15
Pitch date: 2025-05-26
AVTR [bullish]
Avantor, Inc.
-13.21%
current return
Author Info
No bio for this author
Company Info
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
Market Cap
$7.9B
Pitch Price
$12.87
Price Target
25.00 (+124%)
Dividend
N/A
EV/EBITDA
10.06
P/E
-88.89
EV/Sales
1.74
Sector
Life Sciences Tools and Services
Category
turnaround
Avantor, Inc. - $AVTR
AVTR: Sentiment near bottom, downside minimal vs potential upside. Lab Solutions under proven leader Corey Walker (former division president) after leadership gap. Biopharma-exposed (60%), high recurring revenue (80-85%), strong FCF, 10%+ ROIC. 2024 Ingersoll-Rand court filing confirms strategic interest at 17x EBITDA (~$25/share, ~2x). PT: $25
Read full article (6 min)